Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


INFUSION SITE HAEMORRHAGE side effect

What is INFUSION SITE HAEMORRHAGE ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   INFUSION SITE HAEMORRHAGE and Recently Reported Side Effects   INFUSION SITE HAEMORRHAGE and 15 most Active Side Effect polls   INFUSION SITE HAEMORRHAGE and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with INFUSION SITE HAEMORRHAGE

CIFLOX  GEMTUZUMAB  LOVENOX  


Lovenox Side Effects Report #5410910-4
Pharmacist from UNITED STATES reported LOVENOX problem on Aug 09, 2007. Male patient, 66 years of age, weighting 143.3 lb, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: infusion site haemorrhage, thrombocytopenia, . LOVENOX dosage: unknown. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5300878-3
GEMTUZUMAB OZOGAMICIN problem was reported by a Physician from FRANCE on Apr 17, 2007. Male patient, weighting 152.1 lb, was diagnosed with acute myeloid leukaemia and was treated with GEMTUZUMAB OZOGAMICIN. After drug was administered, patient experienced the following problems/side effects: infusion site haemorrhage, thrombocytopenia, . GEMTUZUMAB OZOGAMICIN dosage: SINGLE DOSE: 5.5 MG; CUMULATIVE DOSE: 28.5 MG. During the same period patient was treated with ZOPHREN, IDARUBICIN, ARACYTIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5259180-0
Physician from FRANCE reported GEMTUZUMAB OZOGAMICIN problem on Mar 05, 2007. Male patient, weighting 152.1 lb, was diagnosed with acute myeloid leukaemia and was treated with GEMTUZUMAB OZOGAMICIN. After drug was administered, patient experienced the following problems/side effects: infusion site haemorrhage, thrombocytopenia, . GEMTUZUMAB OZOGAMICIN dosage: SINGLE DOSE: 5.5 MG; CUMULATIVE DOSE: 28.5 MG. During the same period patient was treated with ZOFRAN, IDARUBICIN, ARACYTIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Ciflox Side Effects Report #5588232-0
CIFLOX problem was reported by a Consumer or non-health professional from FRANCE on Jan 04, 2008. Male patient, 76 years of age, was diagnosed with urinary tract infection, arrhythmia, atrial fibrillation and was treated with CIFLOX. After drug was administered, patient experienced the following problems/side effects: anaemia, hypovolaemic shock, infusion site haemorrhage, muscle haemorrhage, respiratory distress, wound haemorrhage, . CIFLOX dosage: unknown. During the same period patient was treated with PREVISCAN, CONTRAMAL, CORDARONE, ATROVENT, BRICANYL. Patient was hospitalized. Patient died on 07/23/2006.


Ciflox Side Effects Report #5597989-4
Consumer or non-health professional from FRANCE reported CIFLOX problem on Jan 04, 2008. Male patient, 76 years of age, was diagnosed with urinary tract infection, arrhythmia, atrial fibrillation and was treated with CIFLOX. After drug was administered, patient experienced the following problems/side effects: anaemia, hypovolaemic shock, infusion site haemorrhage, muscle haemorrhage, respiratory distress, wound haemorrhage, . CIFLOX dosage: unknown. During the same period patient was treated with PREVISCAN, CONTRAMAL, CORDARONE, ATROVENT, BRICANYL. Patient was hospitalized. Patient died on 07/23/2006.

Ciflox Side Effects Report #5537067-3
CIFLOX problem was reported by a Consumer or non-health professional from FRANCE on Nov 26, 2007. Male patient, 76 years of age, was diagnosed with urinary tract infection, arrhythmia, atrial fibrillation and was treated with CIFLOX. After drug was administered, patient experienced the following problems/side effects: anaemia, hypovolaemic shock, infusion site haemorrhage, muscle haemorrhage, respiratory distress, . CIFLOX dosage: unknown. During the same period patient was treated with PREVISCAN, CONTRAMAL, CORDARONE, ATROVENT, BRICANYL, ESIDRIX. Patient was hospitalized. Patient died on 07/23/2006.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about INFUSION SITE HAEMORRHAGE side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about INFUSION SITE HAEMORRHAGE